PBX1 c.381G>T ;(p.A127=)

Variant ID: 1-164761846-G-T

NM_002585.3(PBX1):c.381G>T;(p.A127=)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.

Theranostics
Tang, Jing J; Sui, Cheng-Jun CJ; Wang, Dong-Fang DF; Lu, Xin-Yuan XY; Luo, Gui-Juan GJ; Zhao, Qing Q; Lian, Qiu-Yu QY; Jeong, Seogsong S; Lin, Xi-Meng XM; Zhu, Yan-Jing YJ; Zheng, Bo B; Wu, Rui R; Wang, Qing Q; Liu, Xiao-Long XL; Liu, Jing-Feng JF; Xia, Qiang Q; Wu, Gang G; Gu, Jin J; Wang, Hong-Yang HY; Chen, Lei L
Publication Date: 2020

Variant appearance in text: PBX1: A127A
PubMed Link: 32373219
Variant Present in the following documents:
  • thnov10p5384s2.xlsx, sheet 6
  • thnov10p5384s2.xlsx, sheet 5
View BVdb publication page